Motus GI Holdings Inc (NASDAQ:MOTS) – Analysts at Oppenheimer raised their Q2 2019 EPS estimates for Motus GI in a note issued to investors on Monday, May 13th. Oppenheimer analyst S. Lichtman now anticipates that the company will post earnings of ($0.28) per share for the quarter, up from their previous estimate of ($0.35). Oppenheimer currently has a “Buy” rating and a $10.00 target price on the stock. Oppenheimer also issued estimates for Motus GI’s Q3 2019 earnings at ($0.27) EPS, FY2019 earnings at ($1.05) EPS, FY2020 earnings at ($0.74) EPS and FY2021 earnings at ($0.33) EPS.
Other equities research analysts have also issued research reports about the company. Zacks Investment Research lowered Motus GI from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. Piper Jaffray Companies cut their price target on Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $9.17.
Shares of MOTS stock opened at $4.01 on Thursday. Motus GI has a 52-week low of $2.34 and a 52-week high of $10.66. The company has a quick ratio of 6.31, a current ratio of 6.36 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $86.23 million, a price-to-earnings ratio of -3.26 and a beta of 2.04.
Motus GI (NASDAQ:MOTS) last posted its quarterly earnings data on Friday, May 10th. The company reported ($0.29) EPS for the quarter, hitting the consensus estimate of ($0.29).
A number of hedge funds have recently modified their holdings of MOTS. Hilltop Holdings Inc. increased its holdings in shares of Motus GI by 39.2% in the first quarter. Hilltop Holdings Inc. now owns 152,300 shares of the company’s stock worth $594,000 after buying an additional 42,900 shares during the period. Renaissance Technologies LLC purchased a new position in shares of Motus GI in the first quarter worth about $43,000. Spark Investment Management LLC increased its holdings in shares of Motus GI by 73.5% in the first quarter. Spark Investment Management LLC now owns 28,900 shares of the company’s stock worth $112,000 after buying an additional 12,245 shares during the period. Mesirow Financial Investment Management Inc. purchased a new position in shares of Motus GI in the first quarter worth about $350,000. Finally, RTW Investments LP increased its holdings in shares of Motus GI by 672.5% in the fourth quarter. RTW Investments LP now owns 459,478 shares of the company’s stock worth $1,429,000 after buying an additional 400,000 shares during the period. Institutional investors and hedge funds own 37.49% of the company’s stock.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Featured Article: What is the NASDAQ?
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.